Envela ELA 深 沪
已收盘 09-12 16:00:00 美东时间
7.05
-0.040
-0.56%
华盛通- 最 高7.245
- 今 开7.06
- 成交量 3.79万股
- 最 低 6.96
- 昨 收 7.09
- 总市值 1.83亿
- 52周最高 7.88
- 市盈率 静 27.31
- 换手率 0.15%
- 52周最低 5.10
- 委 比 -33.33%
- 总股本 2599.52万
- 历史最高 28.57
- 量 比 0.68
- 振 幅 4.02%
- 历史最低 1.33
- 每 手 1
- 风险率 0.69%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Electra Signs Term Sheet with Ontario for C$17.5 Million as Part of C$100 Million Cobalt Refinery Investment
Electra Battery Materials Corporation has secured C$17.5 million from Invest Ontario to build North America's first cobalt sulfate refinery in Temiskaming Shores. The facility will produce 6,500 tonnes annually, supporting up to 1 million electric vehicles. This investment aims to enhance Canada's battery supply chain, reduce reliance on foreign sources, and create over 50 jobs. The project aligns with Ontario's economic and clean energy goals, c...
09-12 13:15
AWS & Qualcomm Work With Sony Honda Mobility To Accelerate Development Of AI-Powered AFEELA EV
https://www.shm-afeela.com/en/
09-11 03:36
Insights into Sportsman's Warehouse's Upcoming Earnings
Sportsman's Warehouse (NASDAQ:SPWH) is preparing to release its quarterly earni...
09-04 00:02
Abbvie Secures Health Canada Approval For ELAHERE Under Priority Review To Treat FRα+ Platinum-Resistant Ovarian And Related Cancers
Health Canada has approved ELAHERE®, the first novel therapy to demonstrate statistically significant and clinically meaningful improvements in overall survival (OS) compared to chemotherapy alone for patients with
09-03 00:46
触犯经销商利益，索尼·本田合资公司在美被起诉
导读：在这一争议中，“索尼·本田美国分公司是否能被视为本田汽车美国分公司的关联企业”预计将成为关注焦点。 （文 / 观察者网 周盛明 编辑 / 高莘） 据《日...
08-26 09:56
Alvotech targets 50% U.S. Humira biosimilar market share by year-end as Q2 product revenues rise 77%
Earnings Call Insights: Alvotech (ALVO) Q2 2025 Management View CEO Robert Wessman highlighted strong growth momentum in the first half of the year, citing "strong reorders, successful product launche...
08-14 23:39
B. Riley Securities Maintains Buy on Envela, Raises Price Target to $11
B. Riley Securities maintains Envela (AMEX:ELA) with a Buy and raises the price target from $10 to $11.
08-13 20:36
21.55亿，这家抗生素企业被收购！
（来源：动脉新医药） 当地时间8月7日，生物制药公司CorMedix Inc. (NASDAQ:CRMD)和新型抗生素企业Melinta Therapeuti...
08-08 18:11
Somnigroup International's CorMedix to Acquire Melinta in $300M Deal, Expanding Infectious Disease Portfolio
CorMedix Inc. ("CorMedix") (NASDAQ:CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, and Melinta Therapeutics LLC ("Melinta"),
08-07 19:14
Envela Q2 EPS $0.11 Beats $0.07 Estimate, Sales $54.88M Beat $46.81M Estimate
Envela (AMEX:ELA) reported quarterly earnings of $0.11 per share which beat the analyst consensus estimate of $0.07 by 69.23 percent. This is a 83.33 percent increase over earnings of $0.06 per share from the same period
08-07 04:56
